Alignment HealthcarevsMerck & Company

ALHC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ALHC

Alignment Healthcare, Inc.

$6.64

Value $1.4B

-1.12%
ALHC's page

MRK

Merck & Company, Inc.

$132.65

Value $328B

-3.74%
MRK's page

Alignment Healthcare (ALHC) has a market value of $1.4B and Merck & Company (MRK) $328B. Over the last year, with dividends, ALHC moved -58.8% and MRK +41.6%. The P/E is 46.9 for ALHC and 133.7 for MRK. Dividend yield: ALHC none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ALHC$1.4B

    MRK$328B

    MRK is 242 times ALHC

  • Revenue, 12 months

    ALHC$4.9B

    MRK$67.4B

    MRK is 14 times ALHC

  • Net income, 12 months

    ALHC$29M

    MRK$2.5B

    MRK is 85 times ALHC

  • Operating margin

    ALHC0.9%

    MRK–

  • ROIC

    ALHC6.4%

    MRK3.9%

    2.5 points apart

  • P/E

    ALHC46.9

    MRK133.7

    MRK is 2.8 times ALHC

  • Dividend yield

    ALHC0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    ALHC-69.4%

    MRK+86.0%

    155.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ALHC-69.4%

MRK+86.0%

10020020222023202420252026
Returns by period
PeriodALHCWith dividendsMRKWith dividends
1 year since November 18, 2025-58.8%Price -58.8%+41.6%Price +37.5%
3 years since November 17, 2023+1.5%+0.5% a yearPrice +1.5%+42.9%+12.6% a yearPrice +30.3%
5 years since November 18, 2021-69.4%-21.1% a yearPrice -69.4%+86.0%+13.2% a yearPrice +59.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ALHCAlignment HealthcareMRKMerck & Company

Valuation

ALHCMRK
Valuation
Price$6.64$132.65
Market value$1.4B$328B
Enterprise value (EV)$939M$372B
P/E46.9133.7
P/E, 5-year median–14.8
P/B4.97.3
EV/EBIT21.678.1
Free cash flow yield5.7%4.5%

Results and growth

ALHCMRK
Results and growth
Revenue, 12 months$4.9B$67.4B
Net income, 12 months$29M$2.5B
Free cash flow, 12 months$77M$14.7B
Earnings per share, 12 months$0.13$0.98
Revenue growth, year on year46.1%1.3%
Revenue growth a year, past+32.7%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ALHCMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin0.9%–
Net margin0.6%3.6%
ROIC6.4%3.9%
ROE13.3%5.2%

Balance sheet

ALHCMRK
Balance sheet
Cash$743M$9.7B
Total debt$324M$53.8B
Net debt / EBITDA-5.75.7
Interest cover2.6×2.4×

Dividends and buybacks

ALHCMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ALHC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Alignment Healthcare or Merck & Company?

By market value, Merck & Company ($328B) is about 241.6 times Alignment Healthcare ($1.4B), at today's prices.

How did ALHC and MRK stock do over the last 5 years?

Since November 18, 2021, ALHC's price moved -69.4% and MRK's +59.7%. With dividends: ALHC -69.4% (-21.1% a year), MRK +86.0% (+13.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ALHC or MRK?

The dividend yield at today's price is none for Alignment Healthcare and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ALHC and MRK?

At today's price, the P/E is 46.9 for ALHC and 133.7 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Alignment Healthcare or Merck & Company?

Over the last twelve months, the net margin was 0.6% for Alignment Healthcare and 3.6% for Merck & Company, and the operating margin 0.9% and –. Revenue was $4.9B and $67.4B.

Which is the better investment, Alignment Healthcare or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.